It takes effect Tuesday but its fate is already in doubt. The new FTC rule faces legal challenges and possible opposition ...
The suit accuses the company of falsely advertising rental prices by failing to inform renters of numerous mandatory fees.
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from ‘excess’ ...
The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...
The antitrust agency recently created a rule regarding junk fees, but its application to the multifamily sector is unclear.
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...
The IFA has formally called on the Federal Trade Commission to shift its focus away from increased regulation of the franchise business model, arguing that the commission's recent actions exceed its ...
Prescription benefit managers have been under growing scrutiny from state and federal regulators who have accused them of creating pharmacy deserts by steering consumers to their own pharmacies and ...
Under the terms of the agreement, the FTC said it would send checks and PayPal payments containing full refunds to 6,764 ...